<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="dict8/PMC7467230/results/search/drug/results.xml">
  <result pre="prescription opioid pills to injection of illicitly produced opioids, including" exact="heroin" post="and fentanyl, with concomitant increasing injection of stimulants including"/>
  <result pre="heroin and fentanyl, with concomitant increasing injection of stimulants including" exact="cocaine" post="and methamphetamine [1–3]. As a result, the incidence of"/>
  <result pre="and soft tissue infections, is rising [2, 4–11]. Injection of" exact="fentanyl" post="or heroin alone and in combination with stimulants have"/>
  <result pre="tissue infections, is rising [2, 4–11]. Injection of fentanyl or" exact="heroin" post="alone and in combination with stimulants have led to"/>
  <result pre="extended-release naltrexone (XR-NTX). Methadone is a full opioid agonist and" exact="buprenorphine" post="is a partial opioid agonist, while XR-NTX is an"/>
  <result pre="craving, overdose, and HIV and HCV transmission [14, 15]; and" exact="buprenorphine" post="and XR-NTX also improve HIV viral suppression in people"/>
  <result pre="[16, 17]. Of the 3 MOUDs, access to methadone and" exact="buprenorphine" post="are limited by regulations. Prescribing requires special training outside"/>
  <result pre="waiver from the Drug Enforcement Agency in the case of" exact="buprenorphine" post="or treatment in a federally certified opioid treatment program"/>
  <result pre="about 5% of the nation’s physicians have waivers to prescribe" exact="buprenorphine" post="and most substance use treatment programs do not have"/>
  <result pre="of MOUDs, and for cotreatment of related infections. 7. Eliminate the" exact="buprenorphine" post="waiver, remove patient caps, and offer grant funding for"/>
  <result pre="the requirement for clinicians to obtain a waiver to prescribe" exact="buprenorphine" post="[24]. As outlined in this paper, urgent policy action"/>
  <result pre="infections. One innovative care model combined outpatient parenteral therapy with" exact="buprenorphine" post="treatment and showed similar clinical and drug use outcomes"/>
  <result pre="identified as a major barrier preventing some physicians from integrating" exact="buprenorphine" post="into their practice for the treatment of OUD [49]."/>
  <result pre="Clinical Tools and Resources for Infectious Disease and HIV Clinicians" exact="Buprenorphine" post="practitioner locator https://www.samhsa.gov/medication-assisted-treatment/practitioner-program-data/treatment-practitioner-locator Buprenorphine waiver and training resources https://www.samhsa.gov/medication-assisted-treatment/training-materials-resources/apply-for-practitioner-waiver"/>
  <result pre="for Infectious Disease and HIV Clinicians Buprenorphine practitioner locator https://www.samhsa.gov/medication-assisted-treatment/practitioner-program-data/treatment-practitioner-locator" exact="Buprenorphine" post="waiver and training resources https://www.samhsa.gov/medication-assisted-treatment/training-materials-resources/apply-for-practitioner-waiver Behavioral health treatment services"/>
  <result pre="use disorder treatment https://www.projectshout.org In addition, a reorganization of the" exact="buprenorphine" post="prescribing system is needed. In order to increase the"/>
  <result pre="prescribe MOUD and improve patient access, we recommend eliminating the" exact="buprenorphine" post="waiver requirement, removing the patient caps, and dedicating grant"/>
  <result pre="B. reports providing waiver training courses for providers to become" exact="buprenorphine" post="prescribers through the Providers Clinical Support System. A. W."/>
  <result pre="Cochrane Database Syst Rev2011; (8):CD004145. 16.SpringerSA, QiuJ, Saber-TehraniAS, AlticeFLRetention on" exact="buprenorphine" post="is associated with high levels of maximal viral suppression"/>
  <result pre="use of detoxification services. N Engl J Med2006; 354:2512–4.16760459 39.collab:" exact="Alcohol" post="and Drug Foundation. Medically supervised injecting centreshttps://adf.org.au/insights/medically-supervised-injecting-centres/. Accessed 3"/>
  <result pre="376:367–87.20650518 48.FanucchiLC, WalshSL, ThorntonAC, NuzzoPA, LofwallMROutpatient parenteral antimicrobial therapy plus" exact="buprenorphine" post="for opioid use disorder and severe injection-related infections [published"/>
 </snippets>
</snippetsTree>
